Skip to content

SCHEDULE 13D/AAccepted Jun 26, 6:43 PM ET

Kymera Therapeutics, Inc. SCHEDULE 13D/A

BIOTECHNOLOGY VALUE FUND L P

Accepted (ET)

6:43 PM

Jun 26, 2026

Filed

Jun 26, 2026

Documents

1

Size

27.0 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.